Essential (primary) hypertension
Methodology & AI Transparency ⓘ
Essential (primary) hypertension Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Essential (primary) hypertension (I10; High Blood Pressure & Vascular Health) utilize renal-electrolyte panels [Essential (primary) hypertension I10] and objective Home Seated Blood in Essential (primary) hypertension (I10: Pressure) targets (< 120/75 mmHg (I10)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Federal ICD-10-CM code I10 categorizes Essential (primary) hypertension under High Blood Pressure & Vascular Health.
- 3 Typical cash cost range: Primary evaluation for Essential (primary) hypertension incorporates renal-electrolyte panels [Essential (primary) hypertension I10] and symptom diary review.
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Essential (primary) hypertension (I10): Home Seated Blood in Essential (primary) hypertension (I10: Pressure) & Ankle-Brachial Index (ABI) [Essential (primary) hypertension I10] (1.00 – 1.30 (I10)).
Ask our AI Specialists anything about Essential (primary) hypertension
What Is Essential (primary) hypertension?
Physicians managing Essential (primary) hypertension (I10; High Blood Pressure & Vascular Health) utilize renal-electrolyte panels [Essential (primary) hypertension I10] and objective Home Seated Blood in Essential (primary) hypertension (I10: Pressure) targets (< 120/75 mmHg (I10)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Essential (primary) hypertension (I10, Blood Pressure) reflects venous valve incompetence [Essential (primary) hypertension I10]. longitudinal control is benchmarked via Home Seated Blood in Essential (primary) hypertension (I10: Pressure).
Common Symptoms & Clinical Signs
- • Presentation of Essential (primary) hypertension (I10): cold distal extremities in Essential (primary) hypertension (I10: or diminished peripheral)
- • Secondary Essential (primary) hypertension clinical sign: persistently elevated home in Essential (primary) hypertension (I10: or clinic blood)
- • Symptom flares in Essential (primary) hypertension correlating with Home Seated Blood in Essential (primary) hypertension (I10: Pressure) deviation outside < 120/75 mmHg (I10)
- • Functional blood pressure impact requiring renal-electrolyte panels [Essential (primary) hypertension I10] evaluation (I10)
Essential (primary) hypertension Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I10 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Home Seated Blood in Essential (primary) hypertension (I10: Pressure) | < 120/75 mmHg (I10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Essential (primary) hypertension I10] | 1.00 – 1.30 (I10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Creatinine & in Essential (primary) hypertension (I10: Potassium) | K+ 4.0 – 4.8 mEq/L (I10) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Essential (primary) hypertension
Treatment selection for Essential (primary) hypertension depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Essential (primary) hypertension)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Generic or Brand-Name? What to Ask Your Pharmacist Before You Overpay at the Counter FDA-approved generics must deliver the exact same active medicine into your bloodstream as the brand-name version—yet patients routinely overpay by 80% to 90% simply because nobody checked the pharmacy's cash price vs. the insurance copay. JAMA Internal Medicine / CMS NADAC Price Ledger • 2026-11-01 • Meta-Analysis | N = 18,400 | 98/100 | PMID 35190418 ↗ |
| 7 Questions to Bring to Your Next Doctor Visit (And Why They Work) Patients who bring a simple written list of 5 to 7 focused questions get clearer answers, leave with fewer medication mix-ups, and feel far more confident about their care plan—without making the appointment run longer. BMJ Quality & Safety / Patient Education and Counseling • 2026-11-01 • Systematic Review | N = 4,820 | 96/100 | PMID 34582101 ↗ |
| Meta-analysis of telmisartan vs. Valsartan: Which Works Better for The management of essential high blood pressure? When combined with hydrochlorothiazide, telmisartan was more effective than valsartan. Journal of clinical hypertension (Greenwich, Conn.) • 2010-06-15 • Meta-Analysis | N = 3,762 | 94/100 | PMID 20591086 ↗ |
| New Insights on A Phase III Randomized Controlled Trial Evaluating the real-world benefits and: What a 890-Participant Study Found A total of 890 patients were randomized. Clinical therapeutics • 2026-02-15 • Phase III Randomized Trial | N = 890 | 93/100 | PMID 40945998 ↗ |
| New Insights on Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus: What a 310-Participant Study Found We randomized 310 patients to the treatment groups. Clinical therapeutics • 2018-01-15 • Phase III Randomized Trial | N = 310 | 93/100 | PMID 29248384 ↗ |
Essential (primary) hypertension Patient Community & “People Like Me” Threads
Filter Essential (primary) hypertension community threads and patient logs by age, biological sex, dosage, and treatment duration.